| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor | 1.92e-05 | 2 | 88 | 2 | GO:0016639 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase [NAD(P)+] activity | 1.92e-05 | 2 | 88 | 2 | GO:0004353 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NAD+) activity | 1.92e-05 | 2 | 88 | 2 | GO:0004352 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NADP+) activity | 1.92e-05 | 2 | 88 | 2 | GO:0004354 | |
| GeneOntologyMolecularFunction | amino acid sensor activity | 1.92e-05 | 2 | 88 | 2 | GO:0140785 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 5.74e-05 | 3 | 88 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | AMP binding | 1.04e-04 | 21 | 88 | 3 | GO:0016208 | |
| GeneOntologyMolecularFunction | propionate-CoA ligase activity | 1.15e-04 | 4 | 88 | 2 | GO:0050218 | |
| GeneOntologyMolecularFunction | short-chain fatty acid-CoA ligase activity | 1.15e-04 | 4 | 88 | 2 | GO:0031955 | |
| GeneOntologyMolecularFunction | acetate-CoA ligase activity | 1.15e-04 | 4 | 88 | 2 | GO:0003987 | |
| GeneOntologyMolecularFunction | L-leucine binding | 3.97e-04 | 7 | 88 | 2 | GO:0070728 | |
| GeneOntologyBiologicalProcess | propionate biosynthetic process | 1.76e-05 | 2 | 87 | 2 | GO:0019542 | |
| GeneOntologyBiologicalProcess | acetate biosynthetic process | 1.76e-05 | 2 | 87 | 2 | GO:0019413 | |
| GeneOntologyBiologicalProcess | acetyl-CoA biosynthetic process from acetate | 1.76e-05 | 2 | 87 | 2 | GO:0019427 | |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | 5.79e-05 | 410 | 87 | 9 | GO:0006644 | |
| GeneOntologyBiologicalProcess | short-chain fatty acid biosynthetic process | 1.05e-04 | 4 | 87 | 2 | GO:0051790 | |
| GeneOntologyBiologicalProcess | acetate metabolic process | 1.05e-04 | 4 | 87 | 2 | GO:0006083 | |
| GeneOntologyBiologicalProcess | propionate metabolic process | 1.74e-04 | 5 | 87 | 2 | GO:0019541 | |
| GeneOntologyBiologicalProcess | glutamate biosynthetic process | 1.74e-04 | 5 | 87 | 2 | GO:0006537 | |
| GeneOntologyBiologicalProcess | regulation of COPII vesicle coating | 1.74e-04 | 5 | 87 | 2 | GO:0003400 | |
| GeneOntologyBiologicalProcess | response to aluminum ion | 2.61e-04 | 6 | 87 | 2 | GO:0010044 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | PNPLA6 PLPPR4 FIG4 ACSS1 PGAP1 MDH1B PHB2 LPGAT1 SOCS1 PLPPR3 PFKM ACSS2 SLC25A19 PRDX6 | 2.87e-04 | 1142 | 87 | 14 | GO:0019637 |
| GeneOntologyCellularComponent | mitochondrial matrix | CBR4 MTG2 MRPL37 ACSS1 GLUD1 PYROXD2 GLUD2 COX15 SARDH ACSS2 TST | 9.73e-06 | 523 | 86 | 11 | GO:0005759 |
| GeneOntologyCellularComponent | mitochondrial inner membrane | COX20 MTG2 MRPL37 GLUD1 GLUD2 PHB2 COX15 TST SLC25A19 TIMMDC1 | 1.60e-04 | 593 | 86 | 10 | GO:0005743 |
| GeneOntologyCellularComponent | organelle inner membrane | COX20 MTG2 MRPL37 GLUD1 GLUD2 PHB2 COX15 TST SLC25A19 TIMMDC1 | 3.41e-04 | 652 | 86 | 10 | GO:0019866 |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 5.91e-04 | 9 | 86 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | mitochondrial membrane | COX20 RNF5 MTG2 MRPL37 GLUD1 GLUD2 PHB2 COX15 TST SLC25A19 TIMMDC1 | 8.31e-04 | 866 | 86 | 11 | GO:0031966 |
| GeneOntologyCellularComponent | platelet dense tubular network | 8.98e-04 | 11 | 86 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | mitochondrial envelope | COX20 RNF5 MTG2 MRPL37 GLUD1 GLUD2 PHB2 COX15 TST SLC25A19 TIMMDC1 | 1.26e-03 | 912 | 86 | 11 | GO:0005740 |
| Domain | MIR | 1.14e-05 | 10 | 87 | 3 | PS50919 | |
| Domain | MIR | 1.14e-05 | 10 | 87 | 3 | PF02815 | |
| Domain | MIR | 1.14e-05 | 10 | 87 | 3 | SM00472 | |
| Domain | MIR_motif | 1.14e-05 | 10 | 87 | 3 | IPR016093 | |
| Domain | ELFV_dehydrog_N | 2.14e-05 | 2 | 87 | 2 | PF02812 | |
| Domain | Glu/Leu/Phe/Val_DH_C | 2.14e-05 | 2 | 87 | 2 | IPR006096 | |
| Domain | Glu/Leu/Phe/Val_DH_dimer_dom | 2.14e-05 | 2 | 87 | 2 | IPR006097 | |
| Domain | Glu/Leu/Phe/Val_DH | 2.14e-05 | 2 | 87 | 2 | IPR006095 | |
| Domain | ELFV_dehydrog | 2.14e-05 | 2 | 87 | 2 | PF00208 | |
| Domain | ELFV_dehydrog | 2.14e-05 | 2 | 87 | 2 | SM00839 | |
| Domain | Glu/Leu/Phe/Val_DH_AS | 2.14e-05 | 2 | 87 | 2 | IPR033524 | |
| Domain | Small_GTPase_SAR1 | 2.14e-05 | 2 | 87 | 2 | IPR006687 | |
| Domain | NAD_bind_Glu_DH | 2.14e-05 | 2 | 87 | 2 | IPR033922 | |
| Domain | Ac_CoA_lig | 2.14e-05 | 2 | 87 | 2 | IPR011904 | |
| Domain | SAR1 | 2.14e-05 | 2 | 87 | 2 | PS51422 | |
| Domain | GLFV_DEHYDROGENASE | 2.14e-05 | 2 | 87 | 2 | PS00074 | |
| Domain | InsP3_rcpt-bd | 6.42e-05 | 3 | 87 | 2 | IPR000493 | |
| Domain | ACAS_N | 1.28e-04 | 4 | 87 | 2 | PF16177 | |
| Domain | ACAS_N | 1.28e-04 | 4 | 87 | 2 | IPR032387 | |
| Domain | Cadherin | 2.26e-04 | 118 | 87 | 5 | IPR002126 | |
| Domain | RIH_assoc | 3.18e-04 | 6 | 87 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 3.18e-04 | 6 | 87 | 2 | IPR013662 | |
| Domain | RIH_dom | 3.18e-04 | 6 | 87 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.18e-04 | 6 | 87 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.18e-04 | 6 | 87 | 2 | IPR015925 | |
| Domain | - | 3.18e-04 | 6 | 87 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 3.18e-04 | 6 | 87 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 3.18e-04 | 6 | 87 | 2 | PF08709 | |
| Domain | SIX1_SD | 4.44e-04 | 7 | 87 | 2 | PF16878 | |
| Domain | SIX1_SD | 4.44e-04 | 7 | 87 | 2 | IPR031701 | |
| Domain | Cadherin_tail | 6.76e-04 | 37 | 87 | 3 | PF15974 | |
| Domain | Cadherin_CBD | 6.76e-04 | 37 | 87 | 3 | IPR031904 | |
| Domain | Amino_oxidase | 9.42e-04 | 10 | 87 | 2 | IPR002937 | |
| Domain | Amino_oxidase | 9.42e-04 | 10 | 87 | 2 | PF01593 | |
| Domain | Cadherin_C | 9.83e-04 | 42 | 87 | 3 | IPR032455 | |
| Domain | Cadherin_C_2 | 9.83e-04 | 42 | 87 | 3 | PF16492 | |
| Domain | Cadherin_CS | 1.68e-03 | 109 | 87 | 4 | IPR020894 | |
| Domain | CADHERIN_1 | 1.92e-03 | 113 | 87 | 4 | PS00232 | |
| Domain | Cadherin | 1.92e-03 | 113 | 87 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 1.99e-03 | 114 | 87 | 4 | PS50268 | |
| Domain | - | 1.99e-03 | 114 | 87 | 4 | 2.60.40.60 | |
| Domain | CA | 2.05e-03 | 115 | 87 | 4 | SM00112 | |
| Domain | Cadherin-like | 2.12e-03 | 116 | 87 | 4 | IPR015919 | |
| Domain | - | 2.26e-03 | 56 | 87 | 3 | 3.50.50.60 | |
| Domain | FAD/NAD-binding_dom | 2.38e-03 | 57 | 87 | 3 | IPR023753 | |
| Domain | Chemokine_rcpt | 2.47e-03 | 16 | 87 | 2 | IPR000355 | |
| Domain | AMP-bd_C | 2.79e-03 | 17 | 87 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 2.79e-03 | 17 | 87 | 2 | PF13193 | |
| Domain | - | 3.13e-03 | 18 | 87 | 2 | 1.20.144.10 | |
| Domain | acidPPc | 3.13e-03 | 18 | 87 | 2 | SM00014 | |
| Domain | Cadherin_2 | 3.46e-03 | 65 | 87 | 3 | PF08266 | |
| Domain | Cadherin_N | 3.46e-03 | 65 | 87 | 3 | IPR013164 | |
| Domain | P_Acid_Pase_2/haloperoxidase | 3.86e-03 | 20 | 87 | 2 | IPR000326 | |
| Domain | PAP2 | 3.86e-03 | 20 | 87 | 2 | PF01569 | |
| Domain | AMP-binding_CS | 6.48e-03 | 26 | 87 | 2 | IPR020845 | |
| Domain | WD40_repeat_CS | 7.25e-03 | 164 | 87 | 4 | IPR019775 | |
| Domain | AMP_BINDING | 7.49e-03 | 28 | 87 | 2 | PS00455 | |
| Domain | Small_GTP-bd_dom | 7.72e-03 | 167 | 87 | 4 | IPR005225 | |
| Domain | - | 8.04e-03 | 169 | 87 | 4 | 3.40.50.720 | |
| Domain | AMP-binding | 8.57e-03 | 30 | 87 | 2 | PF00501 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 1.72e-05 | 11 | 68 | 3 | MM14866 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 2.27e-04 | 5 | 68 | 2 | M49000 | |
| Pathway | BIOCARTA_WNT_LRP6_PATHWAY | 3.40e-04 | 6 | 68 | 2 | MM1588 | |
| Pathway | BIOCARTA_WNT_LRP6_PATHWAY | 3.40e-04 | 6 | 68 | 2 | M22083 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 3.40e-04 | 6 | 68 | 2 | M47960 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | BMP2K RRP9 MTG2 MRPL37 ACSS1 SAR1B GLUD1 SUPT16H PHB2 COX15 MSI1 PFKM TIMMDC1 NEURL4 RRP1 MSI2 ITPR2 ITPR3 | 3.81e-08 | 1496 | 89 | 18 | 32877691 |
| Pubmed | LRIG2 PNPLA6 SLC4A1AP RRP9 MRPL37 GLUD1 SUPT16H RPS13 PHB2 SDF2L1 COX15 PFKM TIMMDC1 NEURL4 RRP1 ITPR2 ITPR3 | 1.99e-07 | 1487 | 89 | 17 | 33957083 | |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | CBR4 COX20 MTG2 MRPL37 ACSS1 GLUD1 GLUD2 PHB2 COX15 SARDH TST SLC25A19 TIMMDC1 PRDX6 | 4.31e-07 | 1047 | 89 | 14 | 18614015 |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | CBR4 COX20 MTG2 MRPL37 ACSS1 GLUD1 PHB2 COX15 SARDH TST SLC25A19 TIMMDC1 PRDX6 | 6.76e-07 | 926 | 89 | 13 | 20877624 |
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | CBR4 COX20 MTG2 MRPL37 ACSS1 GLUD1 PYROXD2 GLUD2 PHB2 COX15 SARDH TST SLC25A19 TIMMDC1 | 1.13e-06 | 1136 | 89 | 14 | 34800366 |
| Pubmed | KIF20A GTPBP2 SALL2 PNPLA6 HMCN2 SH3TC1 SUPT16H MSI1 WDFY3 KDM1B SLC25A19 BRWD1 WDR72 | 5.24e-06 | 1116 | 89 | 13 | 31753913 | |
| Pubmed | Crystal and solution structures of human oncoprotein Musashi-2 N-terminal RNA recognition motif 1. | 6.48e-06 | 2 | 89 | 2 | 31603583 | |
| Pubmed | Focus on molecules: Wnt8b: a suppressor of early eye and retinal progenitor formation. | 6.48e-06 | 2 | 89 | 2 | 21219900 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 15750346 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 35809272 | ||
| Pubmed | Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. | 6.48e-06 | 2 | 89 | 2 | 9065779 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 1711373 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 32245259 | ||
| Pubmed | Expression of RNA-binding protein Musashi in hair follicle development and hair cycle progression. | 6.48e-06 | 2 | 89 | 2 | 16400011 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 34173171 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 28621566 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 23054685 | ||
| Pubmed | Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve. | 6.48e-06 | 2 | 89 | 2 | 17496801 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 32078638 | ||
| Pubmed | Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate. | 6.48e-06 | 2 | 89 | 2 | 20529287 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 23595828 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 25124006 | ||
| Pubmed | Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye. | 6.48e-06 | 2 | 89 | 2 | 24901844 | |
| Pubmed | Unexpected histone H3 tail-clipping activity of glutamate dehydrogenase. | 6.48e-06 | 2 | 89 | 2 | 23673664 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 33854148 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 21621574 | ||
| Pubmed | Lack of evidence for direct ligand-gated ion channel activity of GluD receptors. | 6.48e-06 | 2 | 89 | 2 | 39052831 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 24442550 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 28911206 | ||
| Pubmed | The Musashi proteins MSI1 and MSI2 are required for photoreceptor morphogenesis and vision in mice. | 6.48e-06 | 2 | 89 | 2 | 33168629 | |
| Pubmed | The Amplifying Pathway of the β-Cell Contributes to Diet-induced Obesity. | 6.48e-06 | 2 | 89 | 2 | 27137930 | |
| Pubmed | GDH-Dependent Glutamate Oxidation in the Brain Dictates Peripheral Energy Substrate Distribution. | 6.48e-06 | 2 | 89 | 2 | 26440896 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 22875990 | ||
| Pubmed | Msi RNA-binding proteins control reserve intestinal stem cell quiescence. | 6.48e-06 | 2 | 89 | 2 | 27799368 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 19528657 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 12742085 | ||
| Pubmed | Molecular basis of human glutamate dehydrogenase regulation under changing energy demands. | 6.48e-06 | 2 | 89 | 2 | 15578726 | |
| Pubmed | Important role of Ser443 in different thermal stability of human glutamate dehydrogenase isozymes. | 6.48e-06 | 2 | 89 | 2 | 15044002 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 19617323 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 8063813 | ||
| Pubmed | The RNA-binding protein Musashi is required intrinsically to maintain stem cell identity. | 6.48e-06 | 2 | 89 | 2 | 16717192 | |
| Pubmed | Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. | 6.48e-06 | 2 | 89 | 2 | 8081734 | |
| Pubmed | Induction of excitatory and inhibitory presynaptic differentiation by GluD1. | 6.48e-06 | 2 | 89 | 2 | 22138648 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 22829007 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 34220417 | ||
| Pubmed | Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state. | 6.48e-06 | 2 | 89 | 2 | 25380226 | |
| Pubmed | Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues. | 6.48e-06 | 2 | 89 | 2 | 26241911 | |
| Pubmed | Functional overlap between the mammalian Sar1a and Sar1b paralogs in vivo. | 6.48e-06 | 2 | 89 | 2 | 38687799 | |
| Pubmed | Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate. | 6.48e-06 | 2 | 89 | 2 | 11150295 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 22113197 | ||
| Pubmed | Glucose-independent Acetate Metabolism Promotes Melanoma Cell Survival and Tumor Growth. | 6.48e-06 | 2 | 89 | 2 | 27539851 | |
| Pubmed | Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets. | 6.48e-06 | 2 | 89 | 2 | 28143872 | |
| Pubmed | Chemokine receptor mRNA expression at the in vitro blood-brain barrier during HIV infection. | 6.48e-06 | 2 | 89 | 2 | 10094132 | |
| Pubmed | Theoretical studies on RNA recognition by Musashi 1 RNA-binding protein. | 6.48e-06 | 2 | 89 | 2 | 35840700 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 21446915 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 21764457 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 18688271 | ||
| Pubmed | IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. | 6.48e-06 | 2 | 89 | 2 | 16195467 | |
| Pubmed | KSHV enhances mesenchymal stem cell homing and promotes KS-like pathogenesis. | 6.48e-06 | 2 | 89 | 2 | 32777727 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 22658952 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 12794150 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 38060673 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 37481823 | ||
| Pubmed | Silencing of mammalian Sar1 isoforms reveals COPII-independent protein sorting and transport. | 6.48e-06 | 2 | 89 | 2 | 23433038 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 26131972 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 24593767 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 12407178 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 24338480 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 15632133 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 38124277 | ||
| Pubmed | Potentiation of neuronal activity by tonic GluD1 current in brain slices. | 6.48e-06 | 2 | 89 | 2 | 37154294 | |
| Pubmed | RNA binding proteins in spermatogenesis: an in depth focus on the Musashi family. | 6.48e-06 | 2 | 89 | 2 | 25851660 | |
| Pubmed | Assessment of MUSASHI 1 and MUSASHI 2 expression in spermatozoa and testicular tissue. | 6.48e-06 | 2 | 89 | 2 | 34309875 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 19015267 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 15713744 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 22924626 | ||
| Pubmed | Interplay between the RNA binding-protein Musashi and developmental signaling pathways. | 6.48e-06 | 2 | 89 | 2 | 31692135 | |
| Pubmed | Modulation of membrane rigidity by the human vesicle trafficking proteins Sar1A and Sar1B. | 6.48e-06 | 2 | 89 | 2 | 22974979 | |
| Pubmed | Human GLUD1 and GLUD2 glutamate dehydrogenase localize to mitochondria and endoplasmic reticulum. | 6.48e-06 | 2 | 89 | 2 | 19448744 | |
| Pubmed | Comparative analysis of Six 3 and Six 6 distribution in the developing and adult mouse brain. | 6.48e-06 | 2 | 89 | 2 | 15973738 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 10584986 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 34768932 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 11032875 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 39446806 | ||
| Pubmed | Molecular analysis of SAR1-related cDNAs from a mouse pituitary cell line. | 6.48e-06 | 2 | 89 | 2 | 8262187 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 34290409 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 11950837 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 25986216 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 29943084 | ||
| Pubmed | Wnt signaling is regulated by endoplasmic reticulum retention. | 6.48e-06 | 2 | 89 | 2 | 19593386 | |
| Pubmed | Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins. | 6.48e-06 | 2 | 89 | 2 | 30097032 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 31898404 | ||
| Pubmed | Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux. | 6.48e-06 | 2 | 89 | 2 | 15378063 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 27422263 | ||
| Pubmed | 8.43e-06 | 50 | 89 | 4 | 26058080 | ||
| Pubmed | 1.05e-05 | 686 | 89 | 10 | 28380382 | ||
| Pubmed | 1.52e-05 | 19 | 89 | 3 | 20890044 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | CBR4 SNED1 BMP2K SLC4A1AP CSPG4 GLUD1 GLUD2 SUPT16H RPS13 PHB2 RHBDD2 SDF2L1 PFKM TIMMDC1 | 1.85e-05 | 1451 | 89 | 14 | 30550785 |
| Pubmed | Rescue of calcineurin Aα(-/-) mice reveals a novel role for the α isoform in the salivary gland. | 1.94e-05 | 3 | 89 | 2 | 21435446 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 29784783 | ||
| Interaction | NCBP2AS2 interactions | 2.82e-06 | 23 | 88 | 4 | int:NCBP2AS2 | |
| Cytoband | 5q31 | 7.74e-05 | 115 | 89 | 4 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 2.96e-04 | 298 | 89 | 5 | chr5q31 | |
| Cytoband | Xp22.32 | 3.84e-04 | 15 | 89 | 2 | Xp22.32 | |
| Cytoband | 10q24 | 2.12e-03 | 35 | 89 | 2 | 10q24 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 2.92e-05 | 3 | 57 | 2 | 297 | |
| GeneFamily | Phospholipid phosphatase related | 9.71e-05 | 5 | 57 | 2 | 1127 | |
| GeneFamily | SINE class homeoboxes | 1.45e-04 | 6 | 57 | 2 | 525 | |
| GeneFamily | AAA ATPases|Mitochondrial respiratory chain complex assembly factors | 2.70e-04 | 40 | 57 | 3 | 645 | |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 4.32e-04 | 10 | 57 | 2 | 1091 | |
| GeneFamily | Clustered protocadherins | 1.08e-03 | 64 | 57 | 3 | 20 | |
| GeneFamily | Acyl-CoA synthetase family | 3.02e-03 | 26 | 57 | 2 | 40 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 4.28e-03 | 31 | 57 | 2 | 357 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-06 | 186 | 89 | 6 | 74c238759c5d3fd39127ec0060d0c2cb16b326d4 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-06 | 187 | 89 | 6 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-06 | 200 | 89 | 6 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | Thalamus-Macroglia-ASTROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.49e-06 | 121 | 89 | 5 | c3a4dfd19b7e8654e859df605d55155b530ad009 | |
| ToppCell | Thalamus-Macroglia-ASTROCYTE-Gja1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.49e-06 | 121 | 89 | 5 | c3efd44bd01c12ef8c7ce4cc351af1540b70a63c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.12e-06 | 133 | 89 | 5 | 840e8240db29cd21ed9830843c0fa6d65b8f300a | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-05 | 149 | 89 | 5 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-05 | 167 | 89 | 5 | fd84a99ea142d1684cdcf4a88ef1d541760bc78a | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 169 | 89 | 5 | 735655e75511c5c41aca667909e8bb52a0ad7fc6 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-05 | 171 | 89 | 5 | 38a05b5ec8ef8f09a2399994c6b4b9a707918ec1 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.47e-05 | 172 | 89 | 5 | dd9ba79e1542fe9fa2c319077d83dd3fc0158f46 | |
| ToppCell | COVID-19_Moderate-NK_CD56bright|COVID-19_Moderate / disease group, cell group and cell class | 2.54e-05 | 173 | 89 | 5 | a07dcb1e555caaa2235aec219334fcbf2d07f10c | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|B_lymphocytes / Location, Cell class and cell subclass | 3.97e-05 | 190 | 89 | 5 | c5c80a6b9087821a2e07250fa90bcd3505f103b6 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.07e-05 | 191 | 89 | 5 | 48cffb55c71bb8b34e926fc461fcd345ce43ea00 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.07e-05 | 191 | 89 | 5 | e4c1c533771b582e21683dbec6f93a558d865e00 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-IPC_like-IPCs/Immature_PNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.49e-05 | 195 | 89 | 5 | 5e36a881fe2646f5a95d07d7b9265e6ada38730c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Stem_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.49e-05 | 195 | 89 | 5 | 2fa0216ba493d9722324c0a9a0c59c40e72b3c4e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Stem_cells-retina_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.49e-05 | 195 | 89 | 5 | 06a437459717dc3c41ec343b1ec57cf910ecbdd8 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-SPP1+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.94e-05 | 199 | 89 | 5 | 7c19f1b1f4369edd035ca9cdcf4e653771fc4648 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.94e-05 | 199 | 89 | 5 | f544229f471b4717166dd4b588399afe45cc31b5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-05 | 199 | 89 | 5 | 4e552015989defc32fe9068e0ba28521b2a1a09c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-05 | 199 | 89 | 5 | 42d57522aa05892f37790d0039d936e065565359 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.94e-05 | 199 | 89 | 5 | 372fb9eb90022dc4ac770a75b4e207c33d1d0c43 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.94e-05 | 199 | 89 | 5 | dd3bf59cdc18091889cbf6c43f37100ba537843d | |
| ToppCell | wk_15-18-Hematologic-Myeloid-SPP1+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.94e-05 | 199 | 89 | 5 | c7fc2ac1601346aac71e7620a8a440fde8d92dbd | |
| ToppCell | cellseq2-Immune-Immune_Myeloid|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.94e-05 | 199 | 89 | 5 | 6c3c9eceea20121ae17ae2462134aa0437f591b3 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-05 | 199 | 89 | 5 | 0554f41ae53c275c92fe692bd999d7578d244fce | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.06e-05 | 200 | 89 | 5 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | mLN-Macrophage|mLN / Region, Cell class and subclass | 5.06e-05 | 200 | 89 | 5 | 68d709afd226241e002dae6d6820bccd1cfd87a1 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-05 | 200 | 89 | 5 | 4b4df0fe47498310d94448b8a289e58e4f5b5aa8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Mesenchymal|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 5.06e-05 | 200 | 89 | 5 | e5b7d9622b96bb20c81ac76b4e60e8b44fa9cca1 | |
| ToppCell | mLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype | 5.06e-05 | 200 | 89 | 5 | 6dcba82a7d322102bae205543086e84c7655b3e0 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.06e-05 | 200 | 89 | 5 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-05 | 200 | 89 | 5 | f11ae9055e72c938b6c9e52701478b2eee681ac4 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-05 | 200 | 89 | 5 | a1ae299cf77580a6d1a728ee591888b6d70a19d6 | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 1.05e-04 | 122 | 89 | 4 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 123 | 89 | 4 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| Drug | adenine N1-oxide | 5.55e-07 | 5 | 88 | 3 | CID000093557 | |
| Drug | N-methylhydantoin | 1.11e-06 | 6 | 88 | 3 | CID000069217 | |
| Drug | AC1MQ2IK | 3.08e-06 | 8 | 88 | 3 | CID003394958 | |
| Drug | acetoacetate | 7.92e-06 | 122 | 88 | 6 | CID000000096 | |
| Drug | phenyltriethoxysilane | 1.48e-05 | 2 | 88 | 2 | CID000013075 | |
| Drug | methylmercuric bromide | 1.48e-05 | 2 | 88 | 2 | CID000068175 | |
| Drug | 5-methylisophthalate | 1.48e-05 | 2 | 88 | 2 | CID000068137 | |
| Drug | adenophostin A | 1.48e-05 | 2 | 88 | 2 | ctd:C085029 | |
| Drug | G-3SH | 1.48e-05 | 2 | 88 | 2 | CID000174237 | |
| Drug | x 1 s | 1.48e-05 | 2 | 88 | 2 | CID000409694 | |
| Drug | iodoacetyldiethylstilbestrol | 1.48e-05 | 2 | 88 | 2 | CID006455327 | |
| Drug | propionyl-AMP | 1.48e-05 | 2 | 88 | 2 | CID000440863 | |
| Drug | 2 pc | 4.37e-05 | 18 | 88 | 3 | CID000440046 | |
| Drug | methoxyethylmercury | 4.42e-05 | 3 | 88 | 2 | CID000115155 | |
| Drug | 4-methylumbelliferyl laurate | 4.42e-05 | 3 | 88 | 2 | CID000600674 | |
| Drug | methylmercuric iodide | 4.42e-05 | 3 | 88 | 2 | CID000067347 | |
| Drug | HCC-1 variant | 4.42e-05 | 3 | 88 | 2 | CID000482146 | |
| Drug | lenthionine | 4.42e-05 | 3 | 88 | 2 | CID000067521 | |
| Drug | mildiomycin | 4.42e-05 | 3 | 88 | 2 | CID000125665 | |
| Drug | succinate | 5.08e-05 | 339 | 88 | 8 | CID000001110 | |
| Drug | asparagine | 5.28e-05 | 53 | 88 | 4 | CID000000236 | |
| Drug | AC1L1CVX | 8.06e-05 | 59 | 88 | 4 | CID000002086 | |
| Drug | methyl benzoquate | 8.82e-05 | 4 | 88 | 2 | CID000026383 | |
| Drug | 8-BDB-TADP | 8.82e-05 | 4 | 88 | 2 | CID000130791 | |
| Drug | cadina-3,9-diene | 8.82e-05 | 4 | 88 | 2 | CID000010657 | |
| Drug | AC1L9CUQ | 8.82e-05 | 4 | 88 | 2 | CID000442451 | |
| Drug | pentenoic acid | 8.82e-05 | 4 | 88 | 2 | CID000012299 | |
| Drug | alpha-ketoglutaramate | 8.82e-05 | 4 | 88 | 2 | CID000000048 | |
| Drug | luxabendazole | 8.82e-05 | 4 | 88 | 2 | CID000072019 | |
| Drug | ureidoglycine | 8.82e-05 | 4 | 88 | 2 | CID000439649 | |
| Drug | N-butylmaleimide | 8.82e-05 | 4 | 88 | 2 | CID000239780 | |
| Drug | Ivin | 8.82e-05 | 4 | 88 | 2 | CID000014083 | |
| Drug | alpha-methylglutamate | 8.82e-05 | 4 | 88 | 2 | CID000095440 | |
| Drug | 2b E2 | 8.82e-05 | 4 | 88 | 2 | CID005327076 | |
| Drug | CGP 39653 | 1.06e-04 | 24 | 88 | 3 | CID006437837 | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 7171_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 3333_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 5601_DN | |
| Drug | dimethyl suberimidate | 1.40e-04 | 68 | 88 | 4 | CID000034750 | |
| Drug | 1-pheg | 1.47e-04 | 5 | 88 | 2 | CID000152041 | |
| Drug | 5'-FSBAzA | 1.47e-04 | 5 | 88 | 2 | CID000130430 | |
| Drug | bathocuproine | 1.47e-04 | 5 | 88 | 2 | CID000065149 | |
| Drug | choline sulfate | 1.47e-04 | 5 | 88 | 2 | CID000000485 | |
| Drug | l-413 | 1.47e-04 | 5 | 88 | 2 | CID000012475 | |
| Drug | AC1NRA4I | 1.47e-04 | 5 | 88 | 2 | CID005287695 | |
| Drug | isosteviol lactone | 1.47e-04 | 5 | 88 | 2 | CID000401559 | |
| Drug | 3-aminopicolinate | 1.47e-04 | 5 | 88 | 2 | CID000073836 | |
| Drug | Thimerosal | BMP2K TPP1 CDHR1 PGAP1 SAR1B SUPT16H LPGAT1 COX15 PLPPR3 WDFY3 AGBL5 ITPR3 SIX6 BRWD1 | 1.95e-04 | 1199 | 88 | 14 | ctd:D013849 |
| Drug | p-cumate | 2.19e-04 | 6 | 88 | 2 | CID000010820 | |
| Drug | alpha-monofluoromethylputrescine | 2.19e-04 | 6 | 88 | 2 | CID000134201 | |
| Drug | dadAB | 2.19e-04 | 6 | 88 | 2 | CID000022626 | |
| Drug | diazonium-1-H-tetrazole | 2.19e-04 | 6 | 88 | 2 | CID000188312 | |
| Drug | AC1L448Y | 2.19e-04 | 6 | 88 | 2 | CID000200389 | |
| Drug | 2-BDB-TAMP | 2.19e-04 | 6 | 88 | 2 | CID000127220 | |
| Drug | 5 fA | 2.19e-04 | 6 | 88 | 2 | CID000193491 | |
| Drug | Emid | 2.19e-04 | 6 | 88 | 2 | CID000074798 | |
| Drug | dimethylmalonate | 2.19e-04 | 6 | 88 | 2 | CID000007943 | |
| Drug | AC1L8SA5 | 2.19e-04 | 6 | 88 | 2 | CID000407285 | |
| Drug | 2-methyl-1,2,3,4-tetrahydroisoquinoline | 2.19e-04 | 6 | 88 | 2 | CID000015362 | |
| Drug | lanosol | 2.19e-04 | 6 | 88 | 2 | CID000078659 | |
| Drug | isodiazinon | 2.19e-04 | 6 | 88 | 2 | CID000133913 | |
| Drug | AMD3100 | 2.27e-04 | 77 | 88 | 4 | CID000065014 | |
| Drug | AC1Q68ZE | 2.51e-04 | 79 | 88 | 4 | CID000000265 | |
| Drug | thionitrobenzoate | 2.80e-04 | 33 | 88 | 3 | CID000123648 | |
| Drug | carbophenothion | 3.06e-04 | 7 | 88 | 2 | CID000013081 | |
| Drug | 37474A | 3.06e-04 | 7 | 88 | 2 | CID004330138 | |
| Drug | AC1L1B5W | 3.06e-04 | 7 | 88 | 2 | CID000001296 | |
| Drug | CID10998045 | 3.06e-04 | 7 | 88 | 2 | CID010998045 | |
| Drug | 2-oxoglutaconic acid | 3.06e-04 | 7 | 88 | 2 | CID006443759 | |
| Drug | d-serine methyl ester hydrochloride | 3.06e-04 | 7 | 88 | 2 | CID000090387 | |
| Disease | fascioliasis (biomarker_via_orthology) | 2.63e-05 | 3 | 88 | 2 | DOID:885 (biomarker_via_orthology) | |
| Disease | Sarcosine measurement | 4.35e-05 | 23 | 88 | 3 | EFO_0021668 | |
| Disease | mental development measurement | 5.62e-05 | 25 | 88 | 3 | EFO_0008230 | |
| Disease | childhood absence epilepsy (biomarker_via_orthology) | 1.31e-04 | 6 | 88 | 2 | DOID:1825 (biomarker_via_orthology) | |
| Disease | xerostomia | 2.43e-04 | 8 | 88 | 2 | EFO_0009869 | |
| Disease | brain ischemia (biomarker_via_orthology) | 2.51e-04 | 102 | 88 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | potassium measurement | 3.32e-04 | 45 | 88 | 3 | EFO_0009283 | |
| Disease | refractive error | 4.40e-04 | 326 | 88 | 6 | MONDO_0004892 | |
| Disease | B-Cell Lymphomas | 5.69e-04 | 12 | 88 | 2 | C0079731 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 5.69e-04 | 12 | 88 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 9.00e-04 | 15 | 88 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Myopia | 9.00e-04 | 15 | 88 | 2 | C0027092 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.27e-03 | 71 | 88 | 3 | EFO_0007878, EFO_0007979 | |
| Disease | Liver diseases | 1.32e-03 | 72 | 88 | 3 | C0023895 | |
| Disease | Liver Dysfunction | 1.32e-03 | 72 | 88 | 3 | C0086565 | |
| Disease | acetate measurement | 1.61e-03 | 20 | 88 | 2 | EFO_0010112 | |
| Disease | Anophthalmia-microphthalmia syndrome | 1.78e-03 | 21 | 88 | 2 | cv:C5680330 | |
| Disease | Hodgkin Disease | 1.95e-03 | 22 | 88 | 2 | C0019829 | |
| Disease | arginine measurement | 2.14e-03 | 23 | 88 | 2 | EFO_0020990 | |
| Disease | Cytochrome-c Oxidase Deficiency | 2.33e-03 | 24 | 88 | 2 | C0268237 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VLSFVHRFVEGRGAT | 136 | Q8NDL9 | |
| ARIGAVHTVIFAGFS | 186 | Q9NUB1 | |
| FAVDRHSGVLRLQAG | 181 | Q96JP9 | |
| SFQVVVRGNGFRHAR | 236 | Q9H6X2 | |
| SQVLFSVTRGARHGE | 466 | Q6UVK1 | |
| ATTFRRGFQVTVHVG | 516 | Q9BX10 | |
| VFSDAVGHARQGRAV | 486 | Q6ZU67 | |
| RHNVILSAGIFFVSA | 131 | O60359 | |
| ARIGALHSIVFAGFS | 181 | Q9NR19 | |
| GSSVGVRVFAVGRHQ | 36 | Q9NSY1 | |
| GFSTVFLVRTHGGIR | 61 | Q9NSY1 | |
| TTNRHRGFGFVTFEN | 146 | Q96DH6 | |
| QSSHFVGVDGVRAFL | 736 | Q9Y5H1 | |
| FNLAGTTVHYVRRGL | 851 | Q8TE59 | |
| VFLVSFVGNRGTFTR | 2321 | Q14571 | |
| FVVSFVGNRGTFIRG | 2296 | Q14573 | |
| FIASGRTGRRNAIHD | 11 | P61925 | |
| FRVAAVNVHGTRGFT | 261 | P23352 | |
| FTGSAFNRSIHRVFQ | 1061 | Q8IY17 | |
| NFGIVSLVHGDFFIR | 136 | Q92604 | |
| LTGGRFRQESHVEFA | 4471 | Q8NDA2 | |
| RFIHGGANVTGFQLV | 251 | P48058 | |
| TYRQHSVVFIGTRSG | 421 | P51805 | |
| GSHFVGVDGVRAFLQ | 741 | Q9Y5H3 | |
| AVVRVGIFTGARVFF | 36 | P08237 | |
| HGVVRRAGVTVDQFS | 936 | Q5H8C1 | |
| RFIISNGLRTEHGVF | 1481 | Q5H8C1 | |
| HVVRFTRSGGNATLQ | 1226 | Q9P2S2 | |
| SSGQHGGRVNLVFFI | 351 | P0CG43 | |
| SARVVGVAHLGEAFR | 156 | Q96EZ4 | |
| LTFRSDARGHAQGFA | 306 | Q8NCW0 | |
| SVSARSGVVFAQRAF | 506 | Q9Y5G1 | |
| VVQSVGTDGRVFHFL | 341 | Q9BZE1 | |
| TNRHRGFGFVTFESE | 146 | O43347 | |
| FTVEGGHRAIFFNRI | 41 | Q99623 | |
| RQVFGTFHQRTVGHT | 61 | Q711Q0 | |
| IQGTVFFAGEATNRH | 786 | Q8NB78 | |
| SVVAGFGHFLFTSRI | 41 | Q5RI15 | |
| VHAVFALRARTVTFG | 136 | P51677 | |
| VHAVFALRARTVTFG | 136 | P32246 | |
| LFRAVSAFGVVGFVR | 86 | Q92562 | |
| ATGRGVFHGIENFIN | 271 | P00367 | |
| GRFGETIEVAHAVVF | 201 | Q8N4T8 | |
| CVAFDRTGHRIFTGS | 191 | Q9NSI6 | |
| QPHGTRGNFFRVVVA | 456 | Q9Y600 | |
| NAHESVRVIVGGRTF | 246 | Q5I0G3 | |
| AFQRRAGGVLVASHL | 176 | P09919 | |
| RRFAHGTAGLVFLTA | 261 | Q7KZN9 | |
| RAFSTRGNLRAHFVG | 666 | Q9Y467 | |
| ATGRGVFHGIENFIN | 271 | P49448 | |
| TRAVRAAGYAHGLVF | 931 | Q96JN8 | |
| GVTFEVHVNTSQRGF | 91 | P15509 | |
| TVFNAHEPFRRGTGV | 136 | Q99942 | |
| AASSYGRGRLVVVSH | 51 | A6NFQ2 | |
| IIGGHVSDRFGRRFI | 161 | Q63ZE4 | |
| ANTTVGRIRFHDFLG | 16 | P30041 | |
| ILRARAVVAFHTGNF | 131 | O95343 | |
| ESVLRARAIVAFHGG | 51 | O95475 | |
| RETFHRGSQGQTERF | 301 | Q9HAT2 | |
| FTTFDLGGHEQARRV | 71 | Q9NR31 | |
| VGRHAASGRVGFVRS | 346 | Q8TE82 | |
| CFSARLRTVFQGVGH | 6 | Q9H4K7 | |
| TSFSQILGQVVRFHG | 581 | Q75T13 | |
| IVARTQRAAGGFTHD | 36 | P56182 | |
| EAHVNGFRFTSVRGD | 681 | Q9Y5B9 | |
| SGPTSIRVHFQAGRF | 121 | O15524 | |
| TGFYRGVSRVTLFTH | 126 | Q8NEG4 | |
| GQVVGHVRRADFGFA | 846 | Q9UL12 | |
| HATLRFNGTRLGAVA | 706 | Q8TER0 | |
| FLRRAVRFVGVHVFG | 171 | Q7Z2D5 | |
| RDVFHVATVASLGRG | 171 | P52198 | |
| GGLRSANRETAFVHA | 76 | Q93098 | |
| NGVYTLNFHGRVTRA | 456 | O00295 | |
| VAGFRGTVRYASVNA | 196 | Q5TCY1 | |
| IFREFGGARCAHNIV | 566 | Q8IZQ1 | |
| IHQGIARRFGFECTA | 351 | O14924 | |
| REAAVRFQHVGTSVF | 156 | Q9HCN8 | |
| RFQHVGTSVFLSVTG | 161 | Q9HCN8 | |
| AVFERRHVIGGAAVT | 61 | Q8N2H3 | |
| TFTGHRDAVSGLAFR | 236 | O43818 | |
| RDAVSGLAFRRGTHQ | 241 | O43818 | |
| FLRRTVRFVGVHVFG | 126 | Q6T4P5 | |
| ERGIGQATHRFTFSQ | 111 | O95235 | |
| FAGNFERTVGTVRHC | 86 | Q6NTF9 | |
| GVILRDSHGVAQVRF | 51 | P62277 | |
| SHFVIAGAVTGSLFR | 166 | Q9NPL8 | |
| QFFAGGEVIAAHRIL | 256 | Q3MJ13 | |
| FRVFGHRTVSVLNGG | 116 | Q16762 | |
| FTTFDLGGHVQARRV | 71 | Q9Y6B6 | |
| AGERVHRVTRSFVGN | 306 | Q96MF2 | |
| VGGFEHARAAFGQVR | 246 | Q9HC21 | |
| LFGGNFAHQASVARV | 246 | O14773 | |
| RVTHIADGVFRFLSN | 346 | O94898 | |
| HVVRFGGSTRLFILQ | 261 | Q9BWU0 |